QurAlis
BioTech/Drugs - Cambridge, Massachusetts, US
QurAlis Details
At QurAlis, we are neuro pioneers on a quest to cure. We work with a relentless pursuit of knowledge, a precise attention to craft, and an optimistic mindset to discover and develop effective precision medicines that have the potential to alter the trajectory of amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other neurodegenerative and neurological diseases. Founded by an internationally recognized team of neurodegenerative biologists from Harvard Medical School and Harvard University, QurAlis is advancing a pipeline with therapeutic candidates that target specific components of ALS and FTD pathology and defined patient populations based on both disease-causing genetic mutation(s) and clinical biomarkers.
QurAlis Technologies
Captcha
reCAPTCHA
Email Providers
Outlook
CMS
WordPress.org
Hosting
Cloudways
Analytics and Tracking
Google Analytics
Other
Mobile Friendly